Table 2 Risks of tertiles log NT-proBNP for mortalities up to 7-year follow-up.
All-cause death | Non-malignancy-related death | CVD-related death | ||||||
|---|---|---|---|---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |||
Unadjusted | Total cohort | T1 | ref | ref | ref | |||
T2 | 2.35 (1.66 to 3.34) | <0.01 | 2.51 (1.72 to 3.67) | <0.01 | 2.68 (1.52 to 4.72) | <0.01 | ||
T3 | 5.08 (3.67 to 7.03) | <0.01 | 5.61 (3.94 to 7.99) | <0.01 | 6.06 (3.56 to 10.31) | <0.01 | ||
Group-Y | T1 | ref | ref | ref | ||||
T2 | 2.60 (1.40 to 4.85) | <0.01 | 3.33 (1.57 to 7.06) | <0.01 | 2.84 (1.11 to 7.27) | 0.03 | ||
T3 | 6.99 (3.95 to 12.36) | <0.01 | 9.71 (4.84 to 19.45) | <0.01 | 8.37 (3.55 to 19.74) | <0.01 | ||
Group-O | T1 | ref | ref | ref | ||||
T2 | 1.21 (0.83 to 1.76) | 0.32 | 1.24 (0.83 to 1.84) | 0.29 | 1.71 (0.90 to 3.24) | 0.1 | ||
T3 | 2.17 (1.52 to 3.09) | <0.01 | 2.38 (1.64 to 3.44) | <0.01 | 2.65 (1.42 to 4.96) | <0.01 | ||
Adjusted | Total cohort | T1 | ref | ref | ref | |||
T2 | 1.49 (1.01 to 2.20) | 0.04 | 1.50 (0.99 to 2.26) | 0.06 | 1.73 (0.93 to 3.19) | 0.08 | ||
T3 | 2.36 (1.59 to 3.51) | <0.01 | 2.35 (1.54 to 3.59) | <0.01 | 2.93 (1.57 to 5.46) | <0.01 | ||
Group-Y | T1 | ref | ref | ref | ||||
T2 | 1.70 (0.89 to 3.25) | 0.11 | 2.07 (0.95 to 4.51) | 0.07 | 1.91 (0.72 to 5.06) | 0.20 | ||
T3 | 2.95 (1.54 to 5.67) | <0.01 | 3.78 (1.74 to 8.22) | <0.01 | 3.66 (1.39 to 9.65) | 0.01 | ||
Group-O | T1 | ref | ref | ref | ||||
T2 | 1.00 (0.64 to 1.58) | 1.00 | 0.98 (0.61 to 1.55) | 0.92 | 1.51 (0.72 to 3.16) | 0.27 | ||
T3 | 1.50 (0.94 to 2.40) | 0.09 | 1.49 (0.92 to 2.41) | 0.10 | 1.88 (0.85 to 4.17) | 0.12 | ||
